Royal Bank Of Canada Raises Addus HomeCare (NASDAQ:ADUS) Price Target to $134.00

Addus HomeCare (NASDAQ:ADUS) had its target price raised by equities research analysts at Royal Bank Of Canada from $133.00 to $134.00 in a report released on Friday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Royal Bank Of Canada’s target price would indicate a potential upside of 13.17% from the company’s current price.

ADUS has been the topic of a number of other reports. JMP Securities reaffirmed a “market outperform” rating and issued a $150.00 target price on shares of Addus HomeCare in a report on Wednesday, July 16th. Barclays lifted their target price on shares of Addus HomeCare from $83.00 to $109.00 and gave the company an “underweight” rating in a report on Tuesday. Macquarie reaffirmed an “outperform” rating and issued a $133.00 target price on shares of Addus HomeCare in a report on Tuesday, June 10th. TD Cowen lifted their target price on shares of Addus HomeCare from $135.00 to $139.00 and gave the company a “buy” rating in a report on Wednesday, August 6th. Finally, Wall Street Zen raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a report on Sunday, June 29th. Two investment analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $138.38.

Addus HomeCare Stock Up 3.7%

ADUS stock opened at $118.41 on Friday. The company’s 50 day moving average is $111.97 and its two-hundred day moving average is $106.99. The stock has a market cap of $2.18 billion, a P/E ratio of 26.14, a PEG ratio of 1.80 and a beta of 0.80. Addus HomeCare has a twelve month low of $88.96 and a twelve month high of $136.72. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.17.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, August 4th. The company reported $1.49 EPS for the quarter, beating analysts’ consensus estimates of $1.45 by $0.04. The business had revenue of $349.44 million for the quarter, compared to analysts’ expectations of $345.71 million. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The company’s quarterly revenue was up 21.8% on a year-over-year basis. During the same period in the previous year, the company posted $1.35 EPS. Research analysts expect that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 2,045 shares of the business’s stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total value of $235,175.00. Following the transaction, the executive vice president directly owned 7,796 shares of the company’s stock, valued at approximately $896,540. The trade was a 20.78% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Veronica Hill-Milbourne sold 1,571 shares of the business’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $114.93, for a total transaction of $180,555.03. Following the completion of the transaction, the director directly owned 5,067 shares in the company, valued at $582,350.31. This represents a 23.67% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 28,616 shares of company stock valued at $3,289,480. 4.50% of the stock is owned by company insiders.

Institutional Investors Weigh In On Addus HomeCare

Institutional investors have recently made changes to their positions in the stock. Natixis boosted its position in shares of Addus HomeCare by 111.9% during the 4th quarter. Natixis now owns 250 shares of the company’s stock worth $31,000 after purchasing an additional 132 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S purchased a new stake in shares of Addus HomeCare during the 1st quarter worth $41,000. State of Wyoming purchased a new stake in shares of Addus HomeCare during the 2nd quarter worth $47,000. Raymond James Financial Inc. purchased a new stake in shares of Addus HomeCare during the 2nd quarter worth $61,000. Finally, CWM LLC boosted its position in shares of Addus HomeCare by 25.3% during the 2nd quarter. CWM LLC now owns 554 shares of the company’s stock worth $64,000 after purchasing an additional 112 shares in the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.